The UK DRI at Cambridge is committed to improving the outlook for people affected by neurodegenerative conditions.

The multi-disciplinary team of researchers have complementary and overlapping expertise in chemistry, biophysics, cell biology, transcriptomics and translational neuroscience.

The Centre is led by Professor Mina Ryten. The scientific focus of the Centre is on mechanisms underlying the earliest stages of disease from genetic risk factors and transcriptomic responses to disease states, through to mechanisms of protein aggregation and spread, and cellular homeostatic mechanisms. The team aim to deliver new mechanistic insights, biomarkers and therapies.

Collaborate with us: 

Find out more about our work at: https://www.ukdri.ac.uk/centres/cambridge